Wednesday Night Creative Writing Group (Main)
Writers of all experience levels are invited to join a casual, peer-supported writing group.
In this group, participants take turns bringing short in-progress or completed pieces of any genre. The group reads several pieces each month, sharing feedback and constructive criticism in a supportive and inclusive environment. We may practice in-class writing exercises and read samples of published writing as time allows.
Registration is required.
For more information, please email Susannah at sbtkacz@cambridgema.gov.
Summer Reading: Capoeira for Everyone with Mass Capoeira at KING OPEN CAFETERIA! (Valente)
Join us for a demonstration of capoeira, a unique Afro-Brazilian art form combining martial arts, dance, music and acrobatics. Following the performance, children will have the opportunity to learn basic capoeira movements. Recommended for children of all ages and their caregivers.
This program will occur in the Cafeteria at King Open.
Funding for Summer Reading has been generously provided by the City of Cambridge, Cambridge Public Library Foundation and Friends of the Cambridge Public Library.
Three Vibrant Mosaic Murals Installed at New Cambridge School Complex
The new Tobin Montessori and Darby Vassall Upper Schools and Community Complex features three mosaic murals that bring color, connection, and meaning to the school environment. Funded through Cambridge's Percent-for-Art Ordinance and commissioned by Cambridge Arts, the works by artists Andromeda Lisle, Amanda Phingbodhipakkiya, and Ekua Holmes celebrate themes of community, memory, and belonging. Developed in collaboration with the school community, architects, the project team, and fabricator Mosaika Art & Design, the murals serve as both inspiration and teaching tools for the school community.
Daily Log 1.25.2023
An overview of the Cambridge Police Department's daily calls for service for January 25th, 2023
FDA Approves First COVID-19 Vaccine
Today (August 23, 2021), the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.